NAVIDEA BIOPHARMACEUTICALS INC S-1

NAVIDEA BIOPHARMACEUTICALS INC, which is in the In Vitro & In Vivo Diagnostic Substances [2835] industry, SEC S-1 filing on February 14, 2022 had 23116 (cleaned) words - 600 were utilized for the visualizations.

Top Words:

1. subscription - 493 instances
2. rights - 474 instances
3. stock - 421 instances
4. offering - 292 instances
5. shares - 289 instances

See the parsed data used in the visualization here.
View the actual filing on the SEC website here